Abstract The 1989 Saint Vincent Declaration established a goal of halving global diabetes‐
related amputation rates. A generation later, this goal has been achieved for major but not …

There are> 12 million patients with peripheral artery disease in the United States. The most
severe form of peripheral artery disease is critical limb ischemia (CLI). The diagnosis and …

Purpose: To evaluate the midterm results of patients suffering from no-option chronic limb-
threatening ischemia (CLTI) treated with a dedicated system for percutaneous deep venous …

Purpose: To evaluate the roles of small artery disease (SAD) and medial arterial calcification
(MAC) in patients with chronic limb-threatening ischemia (CLTI) and to identify any …

Chronic limb-threatening ischemia (CLTI) represents the end-stage form of peripheral
arterial disease (PAD) and is associated with a very poor prognosis and high risk of limb …

Vascular calcifications in aorto-iliac arteries are emerging as crucial risk factors for
cardiovascular diseases (CVDs) with profound clinical implications. This systematic review …

Background Cell therapy with autologous peripheral blood mononuclear cells (PB-MNCs)
may help restore limb perfusion in patients with diabetes mellitus and critical limb …

Patients with chronic limb-threatening ischemia, the terminal stage of peripheral artery
disease, are frequently afflicted by below-the-knee disease. Although all patients should …

The current study aimed to evaluate the effectiveness of peripheral blood mononuclear cell
(PB-MNC) therapy as adjuvant treatment for patients with diabetic foot ulcers (DFUs) and no …

Peripheral blood mononuclear cells (PBMNCs) are reported to prevent major amputation
and healing in no-option critical limb ischemia (NO-CLI). The aim of this study is to evaluate …